Results 231 to 240 of about 78,845 (337)
What's New? About half of penile squamous cell carcinomas are causally associated with inflammatory conditions such as lichen sclerosus (LSc), but few large‐scale studies have assessed the risk of penile cancer in men with LSc. Here, the authors conducted a large nationwide study in Denmark to estimate the risk of penile and non‐penile cancer in men ...
Marianne Gardar Stærk+5 more
wiley +1 more source
What's New? Currently, no published data on homologous recombination deficiency (HRD) testing in the setting of molecular tumor boards exist. This study in a cohort of 237 patients encompassing 24 different tumor entities assessed by a molecular tumor board shows that inactivating alterations of BRCA1/2 are not always associated with an elevated ...
Christoph Schubart+26 more
wiley +1 more source
Achalasia or Pseudoachalasia: Incidental Esophagogastric Junction Submucosal Leiomyoma During Peroral Endoscopic Myotomy. [PDF]
Rahima K+4 more
europepmc +1 more source
Endoscopic submucosal tunnel dissection for large superficial esophageal squamous cell neoplasms
Yaqi Zhai
openalex +1 more source
Transcriptional repression of SOX2 by p53 in cancer cells regulates cell identity and migration
What's New? SOX2 is one of the key developmental genes with a reported altered expression in many tumors. The mechanisms underlying SOX2 regulation in cancer, however, remain elusive. This study shows that TP53 transcriptionally regulates SOX2 through binding to its promoter and the SRR2 enhancer.
Patricia Lado‐Fernández+13 more
wiley +1 more source
The incidence of esophageal second primary cancer in head and neck cancer patients. [PDF]
Chiou TW+6 more
europepmc +1 more source
Small cell neuroendocrine carcinoma of the esophagus [PDF]
Chai, Chee-Yin+3 more
core +1 more source
Intrathoracic leak after an Ivor Lewis procedure for an esophageal neoplasm treated with a stent
Natalia Afonso Luis+2 more
openalex +1 more source
What's New? A range of treatment options exist for metastatic esophageal (EC) and gastric cancer (GC). Which modalities or combination thereof are optimal for these malignancies, however, remains uncertain. Here, the authors examined differences in systemic treatment for metastatic EC and GC across hospitals in the Netherlands.
Julie F. M. Geerts+11 more
wiley +1 more source